Patent details

Basic Information

Publication number:

EP2237783

PCT Application Number:

PCT/US/2009/031510

Type:

European Patent Granted for LU

Legal Status:

Revoked

Application number:

EP097042568

PCT Publication Number:

WO/2009/094360

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

METHOD OF OPTIMIZING THE TREATMENT OF PROLIFERATIVE DISEASES MEDIATED BY THE TYROSINE KINASE RECEPTOR KIT WITH IMATINIB

French Title of Invention:

PROCÉDÉ D'OPTIMISATION DU TRAITEMENT DE MALADIES PROLIFÉRATIVES À MÉDIATION PAR RÉCEPTEUR À TYROSINE KINASE KIT AVEC DE L'IMATINIB

German Title of Invention:

VERFAHREN ZUR OPTIMIERUNG DER BEHANDLUNG VON DURCH DEN TYROSINKINASEREZEPTOR KIT VERMITTELTEN PROLIFERATIVEN ERKRANKUNGEN MIT IMATINIB

SPC Number:

Dates

Filing date:

21/01/2009

Grant date:

19/11/2014

EP Publication Date:

19/11/2014

PCT Publication Date:

30/07/2009

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

13/10/2010

EP B1 Publication Date:

19/11/2014

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

21/01/2015

Expiration date:

21/01/2029

Renunciation date:

Revocation date:

27/07/2020

Annulment date:

Owner

From:

21/01/2009

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:

WANG Yanfeng

Address:

United States (US)

2

Name:

WEHRLE Elisabeth

Address:

Germany (DE)

Priority

Priority Number:

22945 P

Priority Date:

23/01/2008

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/506;

Publication

European Patent Bulletin

Issue number:

202115

Publication date:

14/04/2021

Description:

Revocation of the European patent

Filing date	Document type	Number of pages